These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 11129287)
1. Murine tyrosinase expressed by a T7 vector in bone marrow-derived dendritic progenitors effectively prevents and eradicates melanoma tumors in mice. Li J; Holmes LM; Franek KJ; Wagner TE; Wei Y Cancer Gene Ther; 2000 Nov; 7(11):1448-55. PubMed ID: 11129287 [TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene. Murakami T; Tokunaga N; Waku T; Gomi S; Kagawa S; Tanaka N; Fujiwara T Clin Cancer Res; 2004 Jun; 10(11):3871-80. PubMed ID: 15173096 [TBL] [Abstract][Full Text] [Related]
3. A novel nonviral cytoplasmic gene expression system and its implications in cancer gene therapy. Chen X; Li Y; Xiong K; Xie Y; Aizicovici S; Snodgrass R; Wagner TE; Platika D Cancer Gene Ther; 1995 Dec; 2(4):281-9. PubMed ID: 8548582 [TBL] [Abstract][Full Text] [Related]
4. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy. Fassnacht M; Lee J; Milazzo C; Boczkowski D; Su Z; Nair S; Gilboa E Clin Cancer Res; 2005 Aug; 11(15):5566-71. PubMed ID: 16061874 [TBL] [Abstract][Full Text] [Related]
5. Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor. Chen Z; Huang H; Chang T; Carlsen S; Saxena A; Marr R; Xing Z; Xiang J Cancer Gene Ther; 2002 Sep; 9(9):778-86. PubMed ID: 12189528 [TBL] [Abstract][Full Text] [Related]
6. [Construction of eukaryotic expression vector of mouse alpha-fetoprotein cDNA and its expression in dendritic cells and in vitro antitumor effect on hepatoma]. Zeng B; Lu FG; Liu XW; Yang DY; Fang WY; Wang J; Liao AJ; Shi W Ai Zheng; 2005 Nov; 24(11):1332-7. PubMed ID: 16552958 [TBL] [Abstract][Full Text] [Related]
7. Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors. Nukiwa M; Andarini S; Zaini J; Xin H; Kanehira M; Suzuki T; Fukuhara T; Mizuguchi H; Hayakawa T; Saijo Y; Nukiwa T; Kikuchi T Eur J Immunol; 2006 Apr; 36(4):1019-27. PubMed ID: 16525992 [TBL] [Abstract][Full Text] [Related]
8. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis]. Pan JP; Weng YS; Wu QQ Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366 [TBL] [Abstract][Full Text] [Related]
9. Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis. Chattergoon MA; Kim JJ; Yang JS; Robinson TM; Lee DJ; Dentchev T; Wilson DM; Ayyavoo V; Weiner DB Nat Biotechnol; 2000 Sep; 18(9):974-9. PubMed ID: 10973219 [TBL] [Abstract][Full Text] [Related]
10. Efficient transduction and long-term retroviral expression of the melanoma-associated tumor antigen tyrosinase in CD34(+) cord blood-derived dendritic cells. Temme A; Morgenroth A; Schmitz M; Weigle B; Rohayem J; Lindemann D; Füssel M; Ehninger G; Rieber EP Gene Ther; 2002 Nov; 9(22):1551-60. PubMed ID: 12407427 [TBL] [Abstract][Full Text] [Related]
11. [Enhanced translational efficacy of internal ribosomal entry site-mediated mRNA in dendritic cells contributes to efficient induction of antitumor immunity]. Tan XH; Wan YH Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):399-403. PubMed ID: 17456382 [TBL] [Abstract][Full Text] [Related]
12. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors. Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647 [TBL] [Abstract][Full Text] [Related]
14. Use and specificity of breast cancer antigen/milk protein BA46 for generating anti-self-cytotoxic T lymphocytes by recombinant adeno-associated virus-based gene loading of dendritic cells. Liu Y; Chiriva-Internati M; You C; Luo R; You H; Prasad CK; Grizzi F; Cobos E; Klimberg VS; Kay H; Mehta JL; Hermonat PL Cancer Gene Ther; 2005 Mar; 12(3):304-12. PubMed ID: 15565181 [TBL] [Abstract][Full Text] [Related]
15. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT. Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991 [TBL] [Abstract][Full Text] [Related]
17. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
18. Dendritic cell-directed lentivector vaccine induces antigen-specific immune responses against murine melanoma. Yang HG; Hu BL; Xiao L; Wang P Cancer Gene Ther; 2011 May; 18(5):370-80. PubMed ID: 21372855 [TBL] [Abstract][Full Text] [Related]
19. Enhanced transgene expression and effective in vivo antitumor immune responses initiated by dendritic progenitors transfected with a nonviral T7 vector expressing a model tumor antigen. Wei Y; Li J; Chen WY; Yu X; Sticca RP; Wagner TE J Immunother; 2000 Jan; 23(1):75-82. PubMed ID: 10687140 [TBL] [Abstract][Full Text] [Related]
20. [Therapeutic effects of treatment of pancreatic carcinoma by interleukin-23 and apoptotic cell antigen-modified dendritic cell vaccine: experiment with mice]. Tan G; Wang ZY; Yin S Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):943-6. PubMed ID: 16759530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]